Review: could Depo-testosterone cause Injection Site Reaction?


Injection site reaction is found among people who take Depo-Testosterone, especially for people who are male, 40-49 old also take medication Altace, and have Connective tissue disorder . We study 2,955 people who have side effects while taking Depo-testosterone from FDA and social media. Among them, 9 have Injection site reaction. Find out below who they are, when they have Injection site reaction and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Depo-testosterone has active ingredients of testosterone cypionate. It is often used in testosterone. (latest outcomes from Depo-testosterone 2,980 users)

Injection Site Reaction

Injection site reaction has been reported by people with rheumatoid arthritis, psoriasis, multiple sclerosis, psoriatic arthropathy, crohn's disease (latest reports from 32,381 Injection site reaction patients).

On Oct, 17, 2016

2,955 people reported to have side effects when taking Depo-testosterone.
Among them, 9 people (0.3%) have Injection Site Reaction

Number of reports submitted per year:

Could Depo-testosterone cause Injection site reaction?

Gender of people who have Injection Site Reaction when taking Depo-testosterone *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Injection Site Reaction when taking Depo-testosterone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Connective Tissue Disorder (1 person, 11.11%)

Top co-used drugs for these people *:

  • Propranolol (1 person, 11.11%)
  • Prednisone (1 person, 11.11%)
  • Percocet (1 person, 11.11%)
  • Enbrel (1 person, 11.11%)
  • Altace (1 person, 11.11%)

Top other side effects for these people *:

  • Product Contamination (4 people, 44.44%)
  • Injection Site Swelling (3 people, 33.33%)
  • Injection Site Pain (2 people, 22.22%)
  • Injection Site Warmth (1 person, 11.11%)
  • Injection Site Rash (1 person, 11.11%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Injection site reaction when taking Depo-testosterone?

Browse all side effects of Depo-testosterone

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Injection site reaction

Injection site reaction

Could your condition cause Injection site reaction

Injection site reaction

Related studies

Can you answer these questions?

More questions for: Depo-testosterone, Injection site reaction

You may be interested in these reviews

More reviews for: Depo-testosterone, Injection site reaction

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.